NT5E and animal viral hepatitis: In terms of current research progress, CD73 can inhibit the progression of viral hepatitis to a certain extent, promote the formation of fatty liver, delay the progression of steatohepatitis, and promote the progression of liver fibrosis and liver cancer through the adenosine pathway.